{"database": "openregs", "table": "documents", "rows": [["FDA-2012-N-0002-0041", "FDA", "FDA-2012-N-0002", "Freedom of Information Summary NADA 200-534 Melengestrol acetate plus monensin USP plus tylosin phosphate", "Supporting & Related Material", "Freedom of Information Summary", "2013-01-04T05:00:00Z", 2013, 1, null, null, "2013-01-04T17:21:54Z", null, 0, 0, "09000064811a7caf"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2012-N-0002-0041"], "units": {}, "query_ms": 30.190030811354518, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}